Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Report

Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 30, 2022
  • PAGES：167
  • REPORT CODE：GMM1420924
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Non-alcoholic Fatty Liver Disease (NAFLD) Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Zafgen

    • Metabolic Solutions Development

    • Kyorin Pharmaceutical

    • Novartis AG

    • Galmed International

    • Daewoong Pharmaceutical

    • TCM Biotech International

    • Conatus Pharmaceuticals

    • Tobira Therapeutics

    • Phenex Pharmaceuticals

    • Raptor Pharmaceuticals

    • Verva Pharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Type 1

    • Type 2

    • Type 3

    Application:

    • Application 1

    • Application 2

    • Application 3

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Overview

      • 1.1.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Scope and Market Segments

      • 1.1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Characteristics

      • 1.1.3 Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Value and Growth Rate (2017-2028)

    • 1.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Type 1

      • 1.2.2 Type 2

      • 1.2.3 Type 3

    • 1.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Application 1

      • 1.3.2 Application 2

      • 1.3.3 Application 3

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Porter's Five Forces Model Analysis

      • 2.2.3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry PEST Analysis

    • 2.3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry

    Chapter 3 Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market, by Manufacturer

    • 3.1 Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Top 3 Players

    Chapter 4 Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market, by Type (2017-2028)

    • 4.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend, by Type

    • 4.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price Trend, by Type (2017-2028)

    • 4.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis

    • 7.1 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market, by Type

    • 7.2 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market, by Application

    • 7.3 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis and Forecast, by Country

      • 7.3.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis

    • 8.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market, by Type

    • 8.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market, by Application

    • 8.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis and Forecast, by Country

      • 8.3.1 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis

    • 9.1 APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market, by Type

    • 9.2 APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market, by Application

    • 9.3 APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis and Forecast, by Country

      • 9.3.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis

    • 10.1 Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market, by Type

    • 10.2 Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market, by Application

    • 10.3 Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Company Profiles

      • 11.1 Zafgen

        • 11.1.1 Zafgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Zafgen Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Profiles, Application and Specification

        • 11.1.3 Zafgen Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Metabolic Solutions Development

        • 11.2.1 Metabolic Solutions Development Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Profiles, Application and Specification

        • 11.2.3 Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Kyorin Pharmaceutical

        • 11.3.1 Kyorin Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Profiles, Application and Specification

        • 11.3.3 Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Novartis AG

        • 11.4.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Profiles, Application and Specification

        • 11.4.3 Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Galmed International

        • 11.5.1 Galmed International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Profiles, Application and Specification

        • 11.5.3 Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Daewoong Pharmaceutical

        • 11.6.1 Daewoong Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Profiles, Application and Specification

        • 11.6.3 Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 TCM Biotech International

        • 11.7.1 TCM Biotech International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Profiles, Application and Specification

        • 11.7.3 TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Conatus Pharmaceuticals

        • 11.8.1 Conatus Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Profiles, Application and Specification

        • 11.8.3 Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Tobira Therapeutics

        • 11.9.1 Tobira Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Profiles, Application and Specification

        • 11.9.3 Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Phenex Pharmaceuticals

        • 11.10.1 Phenex Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Profiles, Application and Specification

        • 11.10.3 Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Raptor Pharmaceuticals

        • 11.11.1 Raptor Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Profiles, Application and Specification

        • 11.11.3 Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Verva Pharmaceuticals

        • 11.12.1 Verva Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Verva Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Profiles, Application and Specification

        • 11.12.3 Verva Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Investment Prospect and Risk Assessment

    • 12.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Value and Growth Rate (2017-2028)

    • Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Value and Growth Rate (2017-2028)

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size and Growth Rate of Type 1 (2017-2028)

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size and Growth Rate of Type 2 (2017-2028)

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size and Growth Rate of Type 3 (2017-2028)

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size and Growth Rate of Application 1 (2017-2028)

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size and Growth Rate of Application 2 (2017-2028)

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size and Growth Rate of Application 3 (2017-2028)

    • Figure North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share, by Manufacturer in 2021

    • Figure Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share, by Manufacturer in 2022

    • Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Type (2017-2028)

    • Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Type (2017-2028)

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Type (2017-2028)

    • Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value, by Type (2017-2028)

    • Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value Share, by Type (2017-2028)

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price Trend, by Type (2017-2028)

    • Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Type (2017-2028)

    • Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Type (2017-2028)

    • Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Type (2017-2028)

    • Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value, by Type (2017-2028)

    • Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value Share, by Type (2017-2028)

    • Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price Trend, by Type (2017-2028)

    • Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Application (2017-2028)

    • Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Application (2017-2028)

    • Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value, by Application (2017-2028)

    • Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value Share, by Application (2017-2028)

    • Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value Share, by Application (2017-2028)

    • Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Application (2017-2028)

    • Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Application (2017-2028)

    • Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value, by Application (2017-2028)

    • Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value Share, by Application (2017-2028)

    • Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value Share, by Application (2017-2028)

    • Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Import, Consumption and Export (2017-2022)

    • Table North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Type (2017-2028)

    • Table North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Type (2017-2028)

    • Figure North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Type (2017-2028)

    • Table North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Application (2017-2028)

    • Table North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Application (2017-2028)

    • Figure North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Application (2017-2028)

    • Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Canada Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Type (2017-2028)

    • Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Type (2017-2028)

    • Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Type (2017-2028)

    • Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Application (2017-2028)

    • Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Poland Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Table APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Type (2017-2028)

    • Table APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Type (2017-2028)

    • Figure APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Type (2017-2028)

    • Table APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Application (2017-2028)

    • Table APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Application (2017-2028)

    • Figure APAC Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Value and Growth Rate (2017-2028)

    • Table Zafgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Zafgen Product Profiles, Application and Specification

    • Table Zafgen Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Metabolic Solutions Development Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Metabolic Solutions Development Product Profiles, Application and Specification

    • Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kyorin Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kyorin Pharmaceutical Product Profiles, Application and Specification

    • Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Galmed International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Galmed International Product Profiles, Application and Specification

    • Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Daewoong Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Daewoong Pharmaceutical Product Profiles, Application and Specification

    • Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table TCM Biotech International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table TCM Biotech International Product Profiles, Application and Specification

    • Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Conatus Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Conatus Pharmaceuticals Product Profiles, Application and Specification

    • Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Tobira Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tobira Therapeutics Product Profiles, Application and Specification

    • Table Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Phenex Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Phenex Pharmaceuticals Product Profiles, Application and Specification

    • Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Raptor Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Raptor Pharmaceuticals Product Profiles, Application and Specification

    • Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Verva Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Verva Pharmaceuticals Product Profiles, Application and Specification

    • Table Verva Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US